Verde Bio Holdings Stock Current Valuation

APHD Stock  USD 0.0002  0.0001  100.00%   
Valuation analysis of Verde Bio Holdings helps investors to measure Verde Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
0.0002
Please note that Verde Bio's price fluctuation is very steady at this time. Calculation of the real value of Verde Bio Holdings is based on 3 months time horizon. Increasing Verde Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Verde pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Verde Bio Holdings. Since Verde Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Verde Pink Sheet. However, Verde Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.0E-4 Real  8.4E-5 Hype  1.0E-4
The real value of Verde Pink Sheet, also known as its intrinsic value, is the underlying worth of Verde Bio Holdings Company, which is reflected in its stock price. It is based on Verde Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Verde Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.000084
Real Value
0.00
Upside
Estimating the potential upside or downside of Verde Bio Holdings helps investors to forecast how Verde pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Verde Bio more accurately as focusing exclusively on Verde Bio's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details

Verde Bio Holdings Company Current Valuation Analysis

Verde Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Verde Bio Current Valuation

    
  286.8 K  
Most of Verde Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verde Bio Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Verde Bio Holdings has a Current Valuation of 286.8 K. This is 100.0% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The current valuation for all United States stocks is 100.0% higher than that of the company.

Verde Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verde Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Verde Bio could also be used in its relative valuation, which is a method of valuing Verde Bio by comparing valuation metrics of similar companies.
Verde Bio is currently under evaluation in current valuation category among its peers.

Verde Fundamentals

About Verde Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Verde Bio Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verde Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verde Bio Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Verde Pink Sheet

Verde Bio financial ratios help investors to determine whether Verde Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Verde with respect to the benefits of owning Verde Bio security.